Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
US8431563B2 · kind B2 · utility
0Cited by
0References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2011 |
| Grant date | Apr 30, 2013 |
| Priority date | — |
| Expiry date | Sep 13, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof,that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.